Cancer Spit Test Device Market Insights, Global Outlook and Forecast 2022-2028
The latest research study released by Market IntelliX evaluates market size and forecasts of Cancer Spit Test Device in global, including the following market information:
Global Cancer Spit Test Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cancer Spit Test Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cancer Spit Test Device companies in 2021 (%)
The global Cancer Spit Test Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Passive Drool Collection Methods Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Spit Test Device include Biocartis Group, BD, Abbott Laboratories, Roche Holding AG, Qiagen, Agilent Technologies, BioMerieux, Canvax and Color Health Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Cancer Spit Test Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Cancer Spit Test Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Spit Test Device Market Segment Percentages, by Type, 2021 (%)
Passive Drool Collection Methods
Oral Swab Collection Methods
Global Cancer Spit Test Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Spit Test Device Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Laboratories
Oncology Speciality Clinics
Cancer Research Institutes
Others
Global Cancer Spit Test Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Spit Test Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Spit Test Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cancer Spit Test Device revenues share in global market, 2021 (%)
Key companies Cancer Spit Test Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cancer Spit Test Device sales share in global market, 2021 (%)
The report presents profiles of competitors in the market Some of the prominent key players covered:
Biocartis Group
BD
Abbott Laboratories
Roche Holding AG
Qiagen
Agilent Technologies
BioMerieux
Canvax
Color Health Inc
DNA Genotek Inc.
Illumina
Miraclean Technology Co.,Ltd.
Oasis Diagnostics Corporation
PeriRx
Salimetrics
Sarstedt
Siemens Healthineers
Thermo Fisher Scientific
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Cancer Spit Test Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Spit Test Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Spit Test Device Overall Market Size
2.1 Global Cancer Spit Test Device Market Size: 2021 VS 2028
2.2 Global Cancer Spit Test Device Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Cancer Spit Test Device Sales: 2017-2028
3 Company Landscape
3.1 Top Cancer Spit Test Device Players in Global Market
3.2 Top Global Cancer Spit Test Device Companies Ranked by Revenue
3.3 Global Cancer Spit Test Device Revenue by Companies
3.4 Global Cancer Spit Test Device Sales by Companies
3.5 Global Cancer Spit Test Device Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Cancer Spit Test Device Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Cancer Spit Test Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Spit Test Device Players in Global Market
3.8.1 List of Global Tier 1 Cancer Spit Test Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Spit Test Device Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Spit Test Device Market Size Markets, 2021 & 2028
4.1.2 Passive Drool Collection Methods
4.1.3 Oral Swab Collection Methods
4.2 By Type - Global Cancer Spit Test Device Revenue & Forecasts
4.2.1 By Type - Global Cancer Spit Test Device Revenue, 2017-2022
4.2.2 By Type - Global Cancer Spit Test Device Revenue, 2023-2028
4.2.3 By Type - Global Cancer Spit Test Device Revenue Market Share, 2017-2028
4.3 By Type - Global Cancer Spit Test Device Sales & Forecasts
4.3.1 By Type - Global Cancer Spit Test Device Sales, 2017-2022
4.3.2 By Type - Global Cancer Spit Test Device Sales, 2023-2028
4.3.3 By Type - Global Cancer Spit Test Device Sales Market Share, 2017-2028
4.4 By Type - Global Cancer Spit Test Device Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Cancer Spit Test Device Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Diagnostic Laboratories
5.1.4 Oncology Speciality Clinics
5.1.5 Cancer Research Institutes
5.1.6 Others
5.2 By Application - Global Cancer Spit Test Device Revenue & Forecasts
5.2.1 By Application - Global Cancer Spit Test Device Revenue, 2017-2022
5.2.2 By Application - Global Cancer Spit Test Device Revenue, 2023-2028
5.2.3 By Application - Global Cancer Spit Test Device Revenue Market Share, 2017-2028
5.3 By Application - Global Cancer Spit Test Device Sales & Forecasts
5.3.1 By Application - Global Cancer Spit Test Device Sales, 2017-2022
5.3.2 By Application - Global Cancer Spit Test Device Sales, 2023-2028
5.3.3 By Application - Global Cancer Spit Test Device Sales Market Share, 2017-2028
5.4 By Application - Global Cancer Spit Test Device Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Cancer Spit Test Device Market Size, 2021 & 2028
6.2 By Region - Global Cancer Spit Test Device Revenue & Forecasts
6.2.1 By Region - Global Cancer Spit Test Device Revenue, 2017-2022
6.2.2 By Region - Global Cancer Spit Test Device Revenue, 2023-2028
6.2.3 By Region - Global Cancer Spit Test Device Revenue Market Share, 2017-2028
6.3 By Region - Global Cancer Spit Test Device Sales & Forecasts
6.3.1 By Region - Global Cancer Spit Test Device Sales, 2017-2022
6.3.2 By Region - Global Cancer Spit Test Device Sales, 2023-2028
6.3.3 By Region - Global Cancer Spit Test Device Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Cancer Spit Test Device Revenue, 2017-2028
6.4.2 By Country - North America Cancer Spit Test Device Sales, 2017-2028
6.4.3 US Cancer Spit Test Device Market Size, 2017-2028
6.4.4 Canada Cancer Spit Test Device Market Size, 2017-2028
6.4.5 Mexico Cancer Spit Test Device Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Cancer Spit Test Device Revenue, 2017-2028
6.5.2 By Country - Europe Cancer Spit Test Device Sales, 2017-2028
6.5.3 Germany Cancer Spit Test Device Market Size, 2017-2028
6.5.4 France Cancer Spit Test Device Market Size, 2017-2028
6.5.5 U.K. Cancer Spit Test Device Market Size, 2017-2028
6.5.6 Italy Cancer Spit Test Device Market Size, 2017-2028
6.5.7 Russia Cancer Spit Test Device Market Size, 2017-2028
6.5.8 Nordic Countries Cancer Spit Test Device Market Size, 2017-2028
6.5.9 Benelux Cancer Spit Test Device Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Cancer Spit Test Device Revenue, 2017-2028
6.6.2 By Region - Asia Cancer Spit Test Device Sales, 2017-2028
6.6.3 China Cancer Spit Test Device Market Size, 2017-2028
6.6.4 Japan Cancer Spit Test Device Market Size, 2017-2028
6.6.5 South Korea Cancer Spit Test Device Market Size, 2017-2028
6.6.6 Southeast Asia Cancer Spit Test Device Market Size, 2017-2028
6.6.7 India Cancer Spit Test Device Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Cancer Spit Test Device Revenue, 2017-2028
6.7.2 By Country - South America Cancer Spit Test Device Sales, 2017-2028
6.7.3 Brazil Cancer Spit Test Device Market Size, 2017-2028
6.7.4 Argentina Cancer Spit Test Device Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cancer Spit Test Device Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Cancer Spit Test Device Sales, 2017-2028
6.8.3 Turkey Cancer Spit Test Device Market Size, 2017-2028
6.8.4 Israel Cancer Spit Test Device Market Size, 2017-2028
6.8.5 Saudi Arabia Cancer Spit Test Device Market Size, 2017-2028
6.8.6 UAE Cancer Spit Test Device Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Biocartis Group
7.1.1 Biocartis Group Corporate Summary
7.1.2 Biocartis Group Business Overview
7.1.3 Biocartis Group Cancer Spit Test Device Major Product Offerings
7.1.4 Biocartis Group Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.1.5 Biocartis Group Key News
7.2 BD
7.2.1 BD Corporate Summary
7.2.2 BD Business Overview
7.2.3 BD Cancer Spit Test Device Major Product Offerings
7.2.4 BD Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.2.5 BD Key News
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Corporate Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Cancer Spit Test Device Major Product Offerings
7.3.4 Abbott Laboratories Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.3.5 Abbott Laboratories Key News
7.4 Roche Holding AG
7.4.1 Roche Holding AG Corporate Summary
7.4.2 Roche Holding AG Business Overview
7.4.3 Roche Holding AG Cancer Spit Test Device Major Product Offerings
7.4.4 Roche Holding AG Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.4.5 Roche Holding AG Key News
7.5 Qiagen
7.5.1 Qiagen Corporate Summary
7.5.2 Qiagen Business Overview
7.5.3 Qiagen Cancer Spit Test Device Major Product Offerings
7.5.4 Qiagen Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.5.5 Qiagen Key News
7.6 Agilent Technologies
7.6.1 Agilent Technologies Corporate Summary
7.6.2 Agilent Technologies Business Overview
7.6.3 Agilent Technologies Cancer Spit Test Device Major Product Offerings
7.6.4 Agilent Technologies Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.6.5 Agilent Technologies Key News
7.7 BioMerieux
7.7.1 BioMerieux Corporate Summary
7.7.2 BioMerieux Business Overview
7.7.3 BioMerieux Cancer Spit Test Device Major Product Offerings
7.7.4 BioMerieux Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.7.5 BioMerieux Key News
7.8 Canvax
7.8.1 Canvax Corporate Summary
7.8.2 Canvax Business Overview
7.8.3 Canvax Cancer Spit Test Device Major Product Offerings
7.8.4 Canvax Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.8.5 Canvax Key News
7.9 Color Health Inc
7.9.1 Color Health Inc Corporate Summary
7.9.2 Color Health Inc Business Overview
7.9.3 Color Health Inc Cancer Spit Test Device Major Product Offerings
7.9.4 Color Health Inc Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.9.5 Color Health Inc Key News
7.10 DNA Genotek Inc.
7.10.1 DNA Genotek Inc. Corporate Summary
7.10.2 DNA Genotek Inc. Business Overview
7.10.3 DNA Genotek Inc. Cancer Spit Test Device Major Product Offerings
7.10.4 DNA Genotek Inc. Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.10.5 DNA Genotek Inc. Key News
7.11 Illumina
7.11.1 Illumina Corporate Summary
7.11.2 Illumina Cancer Spit Test Device Business Overview
7.11.3 Illumina Cancer Spit Test Device Major Product Offerings
7.11.4 Illumina Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.11.5 Illumina Key News
7.12 Miraclean Technology Co.,Ltd.
7.12.1 Miraclean Technology Co.,Ltd. Corporate Summary
7.12.2 Miraclean Technology Co.,Ltd. Cancer Spit Test Device Business Overview
7.12.3 Miraclean Technology Co.,Ltd. Cancer Spit Test Device Major Product Offerings
7.12.4 Miraclean Technology Co.,Ltd. Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.12.5 Miraclean Technology Co.,Ltd. Key News
7.13 Oasis Diagnostics Corporation
7.13.1 Oasis Diagnostics Corporation Corporate Summary
7.13.2 Oasis Diagnostics Corporation Cancer Spit Test Device Business Overview
7.13.3 Oasis Diagnostics Corporation Cancer Spit Test Device Major Product Offerings
7.13.4 Oasis Diagnostics Corporation Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.13.5 Oasis Diagnostics Corporation Key News
7.14 PeriRx
7.14.1 PeriRx Corporate Summary
7.14.2 PeriRx Business Overview
7.14.3 PeriRx Cancer Spit Test Device Major Product Offerings
7.14.4 PeriRx Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.14.5 PeriRx Key News
7.15 Salimetrics
7.15.1 Salimetrics Corporate Summary
7.15.2 Salimetrics Business Overview
7.15.3 Salimetrics Cancer Spit Test Device Major Product Offerings
7.15.4 Salimetrics Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.15.5 Salimetrics Key News
7.16 Sarstedt
7.16.1 Sarstedt Corporate Summary
7.16.2 Sarstedt Business Overview
7.16.3 Sarstedt Cancer Spit Test Device Major Product Offerings
7.16.4 Sarstedt Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.16.5 Sarstedt Key News
7.17 Siemens Healthineers
7.17.1 Siemens Healthineers Corporate Summary
7.17.2 Siemens Healthineers Business Overview
7.17.3 Siemens Healthineers Cancer Spit Test Device Major Product Offerings
7.17.4 Siemens Healthineers Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.17.5 Siemens Healthineers Key News
7.18 Thermo Fisher Scientific
7.18.1 Thermo Fisher Scientific Corporate Summary
7.18.2 Thermo Fisher Scientific Business Overview
7.18.3 Thermo Fisher Scientific Cancer Spit Test Device Major Product Offerings
7.18.4 Thermo Fisher Scientific Cancer Spit Test Device Sales and Revenue in Global (2017-2022)
7.18.5 Thermo Fisher Scientific Key News
8 Global Cancer Spit Test Device Production Capacity, Analysis
8.1 Global Cancer Spit Test Device Production Capacity, 2017-2028
8.2 Cancer Spit Test Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Spit Test Device Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cancer Spit Test Device Supply Chain Analysis
10.1 Cancer Spit Test Device Industry Value Chain
10.2 Cancer Spit Test Device Upstream Market
10.3 Cancer Spit Test Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Spit Test Device Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Cancer Spit Test Device in Global Market
Table 2. Top Cancer Spit Test Device Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Cancer Spit Test Device Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Cancer Spit Test Device Revenue Share by Companies, 2017-2022
Table 5. Global Cancer Spit Test Device Sales by Companies, (K Units), 2017-2022
Table 6. Global Cancer Spit Test Device Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Cancer Spit Test Device Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Cancer Spit Test Device Product Type
Table 9. List of Global Tier 1 Cancer Spit Test Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Spit Test Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Spit Test Device Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Cancer Spit Test Device Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Cancer Spit Test Device Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Cancer Spit Test Device Sales (K Units), 2017-2022
Table 15. By Type - Global Cancer Spit Test Device Sales (K Units), 2023-2028
Table 16. By Application – Global Cancer Spit Test Device Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Cancer Spit Test Device Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Cancer Spit Test Device Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Cancer Spit Test Device Sales (K Units), 2017-2022
Table 20. By Application - Global Cancer Spit Test Device Sales (K Units), 2023-2028
Table 21. By Region – Global Cancer Spit Test Device Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Cancer Spit Test Device Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Cancer Spit Test Device Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Cancer Spit Test Device Sales (K Units), 2017-2022
Table 25. By Region - Global Cancer Spit Test Device Sales (K Units), 2023-2028
Table 26. By Country - North America Cancer Spit Test Device Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Cancer Spit Test Device Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Cancer Spit Test Device Sales, (K Units), 2017-2022
Table 29. By Country - North America Cancer Spit Test Device Sales, (K Units), 2023-2028
Table 30. By Country - Europe Cancer Spit Test Device Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Cancer Spit Test Device Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Cancer Spit Test Device Sales, (K Units), 2017-2022
Table 33. By Country - Europe Cancer Spit Test Device Sales, (K Units), 2023-2028
Table 34. By Region - Asia Cancer Spit Test Device Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Cancer Spit Test Device Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Cancer Spit Test Device Sales, (K Units), 2017-2022
Table 37. By Region - Asia Cancer Spit Test Device Sales, (K Units), 2023-2028
Table 38. By Country - South America Cancer Spit Test Device Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Cancer Spit Test Device Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Cancer Spit Test Device Sales, (K Units), 2017-2022
Table 41. By Country - South America Cancer Spit Test Device Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Cancer Spit Test Device Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Cancer Spit Test Device Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Cancer Spit Test Device Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Cancer Spit Test Device Sales, (K Units), 2023-2028
Table 46. Biocartis Group Corporate Summary
Table 47. Biocartis Group Cancer Spit Test Device Product Offerings
Table 48. Biocartis Group Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. BD Corporate Summary
Table 50. BD Cancer Spit Test Device Product Offerings
Table 51. BD Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Abbott Laboratories Corporate Summary
Table 53. Abbott Laboratories Cancer Spit Test Device Product Offerings
Table 54. Abbott Laboratories Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Roche Holding AG Corporate Summary
Table 56. Roche Holding AG Cancer Spit Test Device Product Offerings
Table 57. Roche Holding AG Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Qiagen Corporate Summary
Table 59. Qiagen Cancer Spit Test Device Product Offerings
Table 60. Qiagen Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Agilent Technologies Corporate Summary
Table 62. Agilent Technologies Cancer Spit Test Device Product Offerings
Table 63. Agilent Technologies Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. BioMerieux Corporate Summary
Table 65. BioMerieux Cancer Spit Test Device Product Offerings
Table 66. BioMerieux Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Canvax Corporate Summary
Table 68. Canvax Cancer Spit Test Device Product Offerings
Table 69. Canvax Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Color Health Inc Corporate Summary
Table 71. Color Health Inc Cancer Spit Test Device Product Offerings
Table 72. Color Health Inc Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. DNA Genotek Inc. Corporate Summary
Table 74. DNA Genotek Inc. Cancer Spit Test Device Product Offerings
Table 75. DNA Genotek Inc. Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Illumina Corporate Summary
Table 77. Illumina Cancer Spit Test Device Product Offerings
Table 78. Illumina Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Miraclean Technology Co.,Ltd. Corporate Summary
Table 80. Miraclean Technology Co.,Ltd. Cancer Spit Test Device Product Offerings
Table 81. Miraclean Technology Co.,Ltd. Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Oasis Diagnostics Corporation Corporate Summary
Table 83. Oasis Diagnostics Corporation Cancer Spit Test Device Product Offerings
Table 84. Oasis Diagnostics Corporation Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. PeriRx Corporate Summary
Table 86. PeriRx Cancer Spit Test Device Product Offerings
Table 87. PeriRx Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Salimetrics Corporate Summary
Table 89. Salimetrics Cancer Spit Test Device Product Offerings
Table 90. Salimetrics Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Sarstedt Corporate Summary
Table 92. Sarstedt Cancer Spit Test Device Product Offerings
Table 93. Sarstedt Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Siemens Healthineers Corporate Summary
Table 95. Siemens Healthineers Cancer Spit Test Device Product Offerings
Table 96. Siemens Healthineers Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Thermo Fisher Scientific Corporate Summary
Table 98. Thermo Fisher Scientific Cancer Spit Test Device Product Offerings
Table 99. Thermo Fisher Scientific Cancer Spit Test Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Cancer Spit Test Device Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 101. Global Cancer Spit Test Device Capacity Market Share of Key Manufacturers, 2020-2022
Table 102. Global Cancer Spit Test Device Production by Region, 2017-2022 (K Units)
Table 103. Global Cancer Spit Test Device Production by Region, 2023-2028 (K Units)
Table 104. Cancer Spit Test Device Market Opportunities & Trends in Global Market
Table 105. Cancer Spit Test Device Market Drivers in Global Market
Table 106. Cancer Spit Test Device Market Restraints in Global Market
Table 107. Cancer Spit Test Device Raw Materials
Table 108. Cancer Spit Test Device Raw Materials Suppliers in Global Market
Table 109. Typical Cancer Spit Test Device Downstream
Table 110. Cancer Spit Test Device Downstream Clients in Global Market
Table 111. Cancer Spit Test Device Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cancer Spit Test Device Segment by Type
Figure 2. Cancer Spit Test Device Segment by Application
Figure 3. Global Cancer Spit Test Device Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Spit Test Device Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Spit Test Device Revenue, 2017-2028 (US$, Mn)
Figure 7. Cancer Spit Test Device Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cancer Spit Test Device Revenue in 2021
Figure 9. By Type - Global Cancer Spit Test Device Sales Market Share, 2017-2028
Figure 10. By Type - Global Cancer Spit Test Device Revenue Market Share, 2017-2028
Figure 11. By Type - Global Cancer Spit Test Device Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Cancer Spit Test Device Sales Market Share, 2017-2028
Figure 13. By Application - Global Cancer Spit Test Device Revenue Market Share, 2017-2028
Figure 14. By Application - Global Cancer Spit Test Device Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Cancer Spit Test Device Sales Market Share, 2017-2028
Figure 16. By Region - Global Cancer Spit Test Device Revenue Market Share, 2017-2028
Figure 17. By Country - North America Cancer Spit Test Device Revenue Market Share, 2017-2028
Figure 18. By Country - North America Cancer Spit Test Device Sales Market Share, 2017-2028
Figure 19. US Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Cancer Spit Test Device Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Cancer Spit Test Device Sales Market Share, 2017-2028
Figure 24. Germany Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 25. France Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Cancer Spit Test Device Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Cancer Spit Test Device Sales Market Share, 2017-2028
Figure 33. China Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 37. India Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Cancer Spit Test Device Revenue Market Share, 2017-2028
Figure 39. By Country - South America Cancer Spit Test Device Sales Market Share, 2017-2028
Figure 40. Brazil Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Cancer Spit Test Device Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Cancer Spit Test Device Sales Market Share, 2017-2028
Figure 44. Turkey Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Cancer Spit Test Device Revenue, (US$, Mn), 2017-2028
Figure 48. Global Cancer Spit Test Device Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Cancer Spit Test Device by Region, 2021 VS 2028
Figure 50. Cancer Spit Test Device Industry Value Chain
Figure 51. Marketing Channels
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|